On January 26, 2024, the Ree Wynn Foundation hosted a patient-focused drug development meeting for the US Food and Drug Administration (FDA). The meeting was supported by:
- James Wynn – The Ree Wynn Foundation/Co Moderator
- James Valentine – Hyman, Phelps & McNamara/Co Moderator
- A host of iTTP Warriors and caregivers who shared their experiences with iTTP
The meeting
also welcomes the following guest speakers - here are the times and the topics
for their presentations:
- 00:23:53 – FDA Remarks - Dr. Tanya Wroblewski, Deputy Director DNH
- 00:33:06 - Scientific Foundation for iTTP – Dr. Zheng Long, University of Kansas
- 3:17:13 - iTTP treatment overview - Dr. Adam Cuker, University of Pennsylvania
- 5:05:40 – Meeting Summary - Larry Bauer from Hyman, Phelps & McNamara
If you
would like to learn about the experiences of iTTP patients, I recommend you watch
the complete video. If you would like to learn about iTTP and treatments,
please listen to the talks by Dr. Long and Dr. Cuker.
I thank the Ree Wynn Foundation for preparing and hosting this important meeting which is another step to support all iTTP Warriors.
Thanks, Bruce.
@BruceFightsTTP
